Amulet Capital Partners (Amulet), a middle-market private equity investment firm based in Greenwich, Conneticut, focused exclusively on the healthcare sector, has acquired Remedy Health Media (Remedy), a digital health platform that serves patients, caregivers and healthcare providers through a family of trusted health information websites.
Amulet acquired Remedy from Topspin Consumer Partners, a private equity firm focused on the consumer sector. Terms of the transaction were not disclosed.
Remedy delivers inspiring, authentic and action-oriented digital content to patients and healthcare professionals through its portfolio of digital brands, including healthcentral.com, thebody.com and patientpower.info. Pioneers in the space, Remedy’s brands build deep relationships with high value audiences by providing innovative storytelling, award-winning health journalism, news and proven action plans.
Michael Cunnion, CEO of Remedy, says: “We are excited to work with Amulet to further our mission to serve millions of patients, caregivers and healthcare professionals with information and insights to effectively navigate the healthcare landscape. Amulet’s healthcare experience is a perfect strategic complement for our growth strategy, and new funding will allow us to accelerate our impact with the audiences we serve through content investment, new product development, and the addition of new brands.”
Nick Amigone, Partner of Amulet, says: “We expect pharma to further expand its use of digital channels over the next five years, as the industry more fully appreciates the power of this medium to influence patients and healthcare providers at various points in the care continuum. We are excited to partner with Mike Cunnion and his experienced management team to leverage Remedy’s large and growing base of blue-chip, global healthcare partners. Remedy’s ability to deliver a high-value audience to its pharma and healthcare partners will be critical as we look to expand Remedy’s business footprint via organic growth and strategic M&A.”
Avi Uttamchandani, Principal of Amulet, adds: “Amulet is differentiated in our ability to bring extensive financial resources and healthcare experience to our portfolio companies. We see a tremendous opportunity to combine our healthcare expertise with Remedy’s portfolio of digital assets and best-in-class content. Remedy will serve as a platform in the industry as we seek to invest in or acquire complementary businesses that will expand the company’s digital brand portfolio.”
Remedy is the third platform investment in Amulet Capital Partners Fund II, which closed at the end of August with USD650 million in capital commitments. The firm now has over USD1.3 billion in regulatory capital under management.
Houlihan Lokey was exclusive financial advisor to Remedy, and Latham & Watkins provided legal counsel to Amulet.